News FDA to encourage approval of nicotine replacement therapies FDA commissioner wants to create new pathway
News European pharma calls for urgent Brexit medicines deal - but... ABPI and others concerned over potential disruption to supplies
News Catalyst to re-submit rare disease drug after trial success Already approved in EU, Catalyst aiming for FDA filing next year.
News FDA encourages cheap abuse-deterrent painkillers Regulator waiting for non-opioid alternatives to reach the market
Partner Content Partner Content The 10th Annual Social Media in Pharma – Exclusive Speaker I... Social Media in Pharma
News EMA's post-Brexit location to be decided today The location of the European Medicines Agency after Brexit is to be decided today, as representatives of member states vote in a complex secret ballot that could end with a coin toss.
News After internal setbacks, Pfizer buys obesity player Metsera Pfizer's answer to a string of disappointing projects in obesity R&D? Bolt on a promising pipeline from another developer.
Sales & Marketing FH25: Individual centric investing with Steve Seuntjens In a new FH25 podcast episode, Deep Dive editor Eloise McLennan speaks with Steve Seuntjens, Partner at PHS Capital.
